Argatroban as the Preferred Anticoagulant for HIT in Severe Chronic Kidney Disease

Recommendations

Dosing and Administration

Monitoring

Immediate Management of Suspected HIT

Transition to Warfarin

Alternative Agents When Argatroban Unavailable

Hepatic Function Assessment